CLINICAL_TRIALS
trial_result
· 2021-08-09
Clinical Trial Update: A Study Of Treatment Patterns And Clinical Outcomes In Patients Diagnosed With Acute Myeloid Leukemia Who Received Mylotarg in the Real-World
Summary
A completed real-world study evaluating treatment patterns and outcomes in acute myeloid leukemia patients who received Mylotarg (gemtuzumab ozogamicin).
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Pfizer | Conditions: Leukemia, Myeloid, Acute | Status: COMPLETED | Results posted: 2021-08-09